Recent review by the Gabrilovich group has shown lectin-type oxidized LDL receptor 1 (LOX1) has been noted as a specific marker of human PMN-MDSCs to distinguish these cells in blood or tumors in patients with cancer [26, 65, 66]. Here, OLR1 is linked to cancer.